Otelixizumab (ChAglyCD3) is a monoclonal antibody targeting the CD3 antigen on human T cells. It is specifically designed for research applications focusing on Type 1 diabetes. This antibody can be instrumental in studies aimed at understanding T cell behavior and the immune response in diabetic pathology.
Otelixizumab (ChAglyCD3) is a monoclonal antibody targeting the CD3 antigen on human T cells. It is specifically designed for research applications focusing on Type 1 diabetes. This antibody can be instrumental in studies aimed at understanding T cell behavior and the immune response in diabetic pathology.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: